EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gastrointestinal bleeding among oral anticoagulant users: a comprehensive 7-year retrospective review using Türkiye’s national health data system

Nuray Yilmaz Çakmak iD, Naim Ata iD, Serdar Can Güven iD, Emin Gemcioğlu iD, Murat Çağlayan iD, Mahir Ülgü iD, Şuayip Birinci iD

Turkish Journal of Medical Sciences · 01.01.2024 · 54 (5) · 1005-1012

DOI: 10.55730/1300-0144.5879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 01.01.2024. Verfasst von Nuray Yilmaz Çakmak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine Sciences, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkiye. Hauptthemen laut MEDLINE: Gastrointestinal Hemorrhage, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundThe comparative risk of gastrointestinal bleeding (GIB) among users of direct-acting oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) is a topic of ongoing debate. This study leverages a comprehensive national health database to evaluate the incidence of GIB, associated risk factors, and post-bleeding management strategies among anticoagulated patients.MethodsUtilizing the Turkish Ministry of Health's e-Nabız system, we conducted a retrospective analysis of patients treated with DOACs and warfarin from January 2017 to July 2023. GIB events were identified using ICD codes, and comorbidities, prior medication use, interventions, and mortality rates were analyzed. Drug survival and switch patterns post-GIB were also evaluated.ResultsOut of 102,545 patients with a GIB event under anticoagulant treatment, DOAC users were older with a higher prevalence of comorbidities, except for chronic kidney disease, compared to VKA users. The annual incidence of GIB was consistently higher in the DOAC group. Despite similar usage rates of gastroprotective and other GI irritant drugs, DOAC users had a marginally higher mortality rate following GIB. Notably, nearly half of the patients discontinued anticoagulation therapy post-GIB, with the highest discontinuation observed in apixaban users.ConclusionThis nationwide study indicates a higher frequency of GIB in DOAC users versus VKA users, with age and comorbidities potentially contributing to this trend. Mortality rates were comparable to previous literature but warrant further investigation. The significant discontinuation rate post-GIB raises concerns about ongoing anticoagulation management. These findings underscore the need for cautious

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal HemorrhageAnticoagulantsHumansRetrospective StudiesMaleFemaleAgedMiddle AgedTurkeyAdministration, OralWarfarinAged, 80 and overRisk FactorsIncidenceVitamin KDatabases, FactualAdult

Stichwörter der Autor:innen

Direct oral anticoagulantsbig datagastrointestinal bleedingvitamin K antagonistswarfarin

Substanzen

AnticoagulantsWarfarinVitamin K

Autor:innen und Institutionen

  • Department of Internal Medicine Sciences, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkiye.
  • Department of Strategy Development, Republic of Türkiye Ministry of Health, Ankara, Turkiye.
  • Division of Rheumatology, Department of Internal Medicine Sciences, Ankara Bilkent City Hospital, Ankara, Turkiye.
  • Department of Internal Medicine Sciences, Faculty of Medicine, Health Sciences University, Ankara, Turkiye.
  • Department of Microbiology Sciences, Faculty of Medicine, Health Sciences University, Ankara, Turkiye.
  • Republic of Türkiye Ministry of Health, General Directorate of Health Information System, Ankara, Turkiye.

ORCID-Profile: Nuray Yilmaz Çakmak, Naim Ata, Serdar Can Güven, Emin Gemcioğlu, Murat Çağlayan, Mahir Ülgü, Şuayip Birinci

Zitieren

APA

Yilmaz Çakmak, N., Ata, N., Güven, S. C., Gemcioğlu, E., Çağlayan, M., Ülgü, M., & Birinci, Ş. (2024). Gastrointestinal bleeding among oral anticoagulant users: a comprehensive 7-year retrospective review using Türkiye’s national health data system. Turkish Journal of Medical Sciences, 54(5), 1005-1012. https://doi.org/10.55730/1300-0144.5879

Vancouver

Yilmaz Çakmak N, Ata N, Güven SC, Gemcioğlu E, Çağlayan M, Ülgü M, et al. Gastrointestinal bleeding among oral anticoagulant users: a comprehensive 7-year retrospective review using Türkiye’s national health data system. Turkish Journal of Medical Sciences. 2024;54(5):1005-1012. doi:10.55730/1300-0144.5879

BibTeX
@article{Yilmazakmak2024,
  author = {Yilmaz Çakmak, Nuray and Ata, Naim and Güven, Serdar Can and Gemcioğlu, Emin and Çağlayan, Murat and Ülgü, Mahir and Birinci, Şuayip},
  title = {Gastrointestinal bleeding among oral anticoagulant users: a comprehensive 7-year retrospective review using Türkiye’s national health data system},
  journal = {Turkish Journal of Medical Sciences},
  year = {2024},
  volume = {54},
  number = {5},
  pages = {1005--1012},
  doi = {10.55730/1300-0144.5879}
}
Kostenlos starten →